Expression of a single copy of lncRNA:HsrωEP3037 under the control of Scer\GAL4dpp.blk1 causes a mild disruption of photoreceptor cells; expression of two copies causes high mortality during development and severe disruption of photoreceptors.
Expression of a single copy of lncRNA:HsrωEP3037 under the control of Scer\GAL4elav-C155 causes an increase in pupal lethality with no effect on lifespan.
Expression of a single copy of lncRNA:HsrωEP3037 under the control of Scer\GAL4ptc-559.1 causes changes in scutellar bristle polarity; expression of two copies causes extra or missing scutellar bristles.
Expression of a single copy of lncRNA:HsrωEP3037 under the control of Scer\GAL4C805 causes partial lethality during the pupal stage, with survivors being very weak; expression of two copies additionally causes wing blistering, male sterility and sex comb malformation, with a reduction in the number of sex comb teeth.
Expression of lncRNA:HsrωEP3037 under the control of Scer\GAL4c825 does not result in sex comb defects.
Expression of lncRNA:HsrωEP3037 under the control of Scer\GAL4GMR.PU results in complete lethality during early stages of development.
Expression of lncRNA:HsrωEP3037 under the control of Scer\GAL4Act5C.PI causes a majority of animals to die before adult stage; pupal mortality is greatly increased and fertility is reduced in flies with two copies of lncRNA:HsrωEP3037; the gender ratio of survivors is skewed in favor of females; flies with a single copy of lncRNA:HsrωEP3037 are fertile, but have reduced fecundity. Expression of lncRNA:HsrωEP3037 under the control of Scer\GAL4Act5C.PI also results in fewer, larger omega speckles in the nucleus.
Expression of one copy of HsrωEP3037 using Scer\GAL4GMR.PF at 25[o]C causes disruption in the organization of ommatidial units in larval eye discs.
Eyes of HsrωEP3037 homozygous flies show disorganisation of ommatidial units.
Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA, lncRNA:HsrωEP3037 has abnormal eye color phenotype, suppressible | partially by lncRNA:HsrωRNAi.Sym.UAS/Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/ lncRNA:Hsromega [+] is an enhancer of visible | adult stage phenotype of Scer\GAL4GMR.PU
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of partially lethal - majority die | pupal stage phenotype of Df(3R)Hrb87F/+, Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of partially lethal - majority die | pupal stage phenotype of Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA, nejF2161A.UAS.Tag:V5
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of abnormal eye color phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of abnormal eye color phenotype of Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of abnormal neuroanatomy phenotype of Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of lethal | pupal stage phenotype of Scer\GAL4GMR.PF, nejΔQ.UAS
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is a non-enhancer of lethal | pupal stage phenotype of Diap1RNAi.UAS.cLa, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of lethal | pupal stage phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of lethal | pupal stage phenotype of Scer\GAL4GMR.PF, Tak1UAS.cTa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-suppressor of lethal | pupal stage phenotype of Scer\GAL4GMR.PF, nejΔQ.UAS
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is a non-suppressor of lethal | pupal stage phenotype of Diap1RNAi.UAS.cLa, Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, lncRNA:HsrωEP3037, rprGMR.PW has eye phenotype, suppressible by lncRNA:HsrωRNAi.Sym.UAS/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, grimGMR.PH, lncRNA:HsrωEP3037 has eye phenotype, suppressible by lncRNA:HsrωRNAi.Sym.UAS/Scer\GAL4GMR.PF
Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA, lncRNA:HsrωEP3037 has eye phenotype, suppressible | partially by lncRNA:HsrωRNAi.Sym.UAS/Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/ lncRNA:Hsromega [+] is an enhancer of eye phenotype of Scer\GAL4GMR.PU
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Df(3R)Hrb87F/+, Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA, nejF2161A.UAS.Tag:V5
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, nejF2161A.UAS.Tag:V5
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, nejΔNZK.UAS
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, nejRNAi.UAS.cKa
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Diap1RNAi.UAS.cLa, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye photoreceptor cell | third instar larval stage phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of embryonic/larval optic stalk phenotype of Scer\GAL4GMR.PF, egrUAS.cIa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, Tak1UAS.cTa
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of rprGMR.PW
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of grimGMR.PH
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of eye phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of retina phenotype of Hsap\ATXN3tr.Q78.UAS.Tag:HA, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is an enhancer of rhabdomere phenotype of Hsap\HTTQ93.ex1.UAS, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is an enhancer of eye phenotype of Scer\GAL4GMR.PF, Zzzz\CAG127Q.UAS.Tag:HA
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Scer\GAL4GMR.PF, nejΔBHQ.UAS
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Scer\GAL4GMR.PF, Traf4EP578
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of hidGMR.PG
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Hsap\MAPTUAS.cWa, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Hsap\MAPTV337M.UAS, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037, Scer\GAL4GMR.PF is a non-enhancer of eye phenotype of Hsap\MAPTR406W.UAS, Scer\GAL4GMR.PF
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-suppressor of eye phenotype of Scer\GAL4GMR.PF, nejΔBHQ.UAS
lncRNA:HsrωEP3037/Scer\GAL4GMR.PF is a non-suppressor of eye phenotype of Scer\GAL4GMR.PF, Traf4EP578
Coexpression of one copy of HsrωEP3037 in the Scer\GAL4GMR.PF, nejF2161A.Scer\UAS.T:SV5\V5 background exaggerates the eye damage.
Co-expression of HsrωEP3037 in the Scer\GAL4GMR.PF, nejdsRNA.Scer\UAS.cKa background enhances eye degeneration with the loss of ommatidial integrity extending to most of the eye.
Co-expression of HsrωEP3037 enhances the eye damage seen in Scer\GAL4GMR.PF, nejΔNZK.Scer\UAS flies.
Scer\GAL4GMR.PF-mediated expression of HsrωEP3037 significantly enhances the rprGMR.PW or grimGMR.PH eye phenotypes, but does not discernibly enhance the WGMR.PG eye phenotype, probably because WGMR.PG eyes are already very damaged.
Scer\GAL4GMR.PF-mediated expression of P{Sym-UAS-Hsrω} eliminates the enhancing effect of HsrωEP3037 on rprGMR.PW or grimGMR.PH eyes as well as reversing the level of degeneration seen in eyes expressing rprGMR.PW or grimGMR.PH alone.
Co-expression of HsrωEP3037 leads to a slight enhancement of the eye phenotype in Scer\GAL4GMR.PF,thdsRNA.Scer\UAS.cLa flies.
Co-expression of HsrωEP3037 has no effect on the pupal lethality of Scer\GAL4GMR.PF,thdsRNA.Scer\UAS.cLa flies.
Coexpression of HsrωEP3037 enhances the Scer\GAL4GMR.PF, egrScer\UAS.cIa eye phenotype, leading to severe head malformations and the formation of black lesions on the eye, though pupal lethality is not increased.
Coexpression of HsrωEP3037 enhances the Scer\GAL4GMR.PF, Tak1Scer\UAS.cTa eye phenotype, though pupal lethality is not increased.
Co-expression of HsrωEP3037 enhances the photoreceptor degeneration phenotype seen in Scer\GAL4GMR.PF, egrScer\UAS.cIa eye discs.
Co-expression of HsrωEP3037 enhances the optic stalk axonal projection phenotype seen in Scer\GAL4GMR.PF, egrScer\UAS.cIa eye discs.
The rough eye phenotype seen in the absence of any responder transgene in animals carrying two copies of Scer\GAL4GMR.PU is enhanced by the addition of lncRNA:HsrωEP3037/+.
Expression of HsrωEP3037 in the Scer\GAL4GMR.PF, Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1, Df(3R)Hrb87F/+ background significantly enhances the appearence of black lesions on the eye surface, and also increases pupal mortality.
Expression of nejF2161A.Scer\UAS.T:SV5\V5 in the Scer\GAL4GMR.PF, Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1 background results in 23% lethality at the pupal stage. Surviving flies show a reduction in eye size and a greater disruption in ommatidial arrays. Additional co-expression of HsrωEP3037 results in a greater reduction in eye size, near complete loss of ommatidial arrays and bristles and the appearence of black lesions on the eye surface. Co-expression of HsrωEP3037 also enhances pupal lethality.
Co-expression of HsrωEP3037 significantly enhances the Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1, Scer\GAL4GMR.PF eye phenotype, leading to extensive black lesions on the eye surface.
Co-expression of a single copy of P{Sym-UAS-Hsrω} eliminates the enhancing effect of HsrωEP3037 expression on the Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1, Scer\GAL4GMR.PF eye phenotype, and also substantially reverses the eye degeneration primarily induced by Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1.
The neurodegeneration phenotype caused by expression of Zzzz\CAG127Q.Scer\UAS.T:Ivir\HA1 under the control of Scer\GAL4GMR.PF is enhanced by co-expression of HsrωEP3037 under the control of Scer\GAL4GMR.PF; extensive black necrotic lesions are seen in the eye.
Separable from: A secondary mutation causing recessive embryonic lethality.